Labcorp Holdings Inc. (NYSE:LH) Shares to Pay Quarterly Dividend of $0.72

Labcorp Holdings Inc. (NYSE:LH) declared a quarterly dividend on Wednesday, October 21st. Shareholders of record on Tuesday, November 24th will be paid a dividend of $0.72 per share by the medical research company on Friday, December 11th. This represents a $2.88 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, November 24th.

Labcorp has a payout ratio of 16.4% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Labcorp to earn $19.69 per share next year, which means the company should continue to be able to cover its $2.88 annual dividend with an expected future payout ratio of 14.6%.

Labcorp Stock Up 0.1%

Shares of NYSE LH traded up $0.26 during mid-day trading on Wednesday, reaching $323.39. The company had a trading volume of 566,716 shares, compared to its average volume of 689,293. The company has a current ratio of 1.80, a quick ratio of 1.53 and a debt-to-equity ratio of 0.69. The firm has a 50 day simple moving average of $320.55 and a two-hundred day simple moving average of $289.98. The stock has a market cap of $26.23 billion, a P/E ratio of 26.75, a PEG ratio of 1.82 and a beta of 0.87. Labcorp has a 52-week low of $244.52 and a 52-week high of $341.80.

Labcorp (NYSE:LH) last released its quarterly earnings results on Thursday, July 30th. The medical research company reported $4.99 EPS for the quarter, topping the consensus estimate of $4.78 by $0.21. The company had revenue of $3.73 billion for the quarter, compared to analyst estimates of $3.71 billion. Labcorp had a return on equity of 16.74% and a net margin of 6.99%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.35 earnings per share. Labcorp has set its FY 2026 guidance at 18.100-18.550 EPS. Sell-side analysts predict that Labcorp will post 18.32 earnings per share for the current year.

Labcorp Company Profile

Labcorp (NYSE: LH), formally Laboratory Corporation of America Holdings, is a global life sciences and healthcare company headquartered in Burlington, North Carolina. The company provides laboratory testing and diagnostic services to physicians, hospitals, health systems, employers, insurers and consumers.

Through its diagnostics operations, Labcorp offers routine and specialty testing, oncology diagnostics, women’s health testing, genetic testing, pathology services and other laboratory services.